Who makes Immune checkpoint inhibitors plus Iscador® Qu.?

Immune checkpoint inhibitors plus Iscador® Qu. is developed by University Hospital, Basel, Switzerland.

What development phase is Immune checkpoint inhibitors plus Iscador® Qu. in?

Immune checkpoint inhibitors plus Iscador® Qu. is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

University Hospital, Basel, Switzerland · FDA-approved active Small molecule Quality 2/100

Generic name	Immune checkpoint inhibitors plus Iscador® Qu.
Sponsor	University Hospital, Basel, Switzerland
Modality	Small molecule
Phase	FDA-approved

No approved indications tracked.

No common side effects on file.

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results